
Creating Next Generation
Smart Cell Therapies
Outpace(TM) is pushing the boundaries of biology to create tailored cell therapy solutions through protein design and custom programming.
Our Approach
Outpace(TM)is combining the design of improved biological functions and cellular control modalities to harness the full complexity of cellular biology to tackle incurable disease. We create mechanism-driven solutions tailor-made to dramatically improve efficacy and safety.
Solve specific problems by reimagining proteins at the structural level, beyond traditional protein engineering
Program cell therapies to have the right response at the right time and place
Rapidly test hypotheses at scale
Solve specific problems by reimagining proteins at the structural level, beyond traditional protein engineering

The Right Solutions for
the Most Important Problems
We use our unique combination of protein design and cell engineering expertise to solve holy grail problems in cell and gene therapy. We use Rosetta, the most advanced protein design software in the world, to custom design new biological functions. Each solution adds new proteins to our physical platform with generalizable functions that we can repurpose to solve future problems.

Protein Design Platform
Physical Platform
Solutions
Design new biological functions
Outpace-owned proteins with
generalizable functions
Solutions to holy grail
problems in cell therapy

Ligand Redesign

Oligomerization and Orientation



Drug-induced Dimerization
Protein Actuator
Logic Gate
Our Platform
Outpace's(TM) technologies can modulate diverse biological functions using different control modalities, providing the opportunity to create the optimal solution. Our versatile platform can be applied across multiple problems in diverse areas of biology.

Pipeline

Strategic collaborations with world-leading biotechnology and pharmaceutical companies are the cornerstone of the Outpace(TM) Business model. In addition to collaboratively developing assets for our partners' portfolios, we are also developing an internal pipeline as the foundation for future development.
Core Values

Team

Adam Murray

Angie Emerson

Emily Bringgold

Jason Yokoyama

Kate Miller

Lesley Jones

Robin Kirkpatrick

Tad Davenport

Allan Wang

Bobby Langan

Erik Hermanns

Jen Running Deer

Kristie Shirley

Marc Lajoie

Runfeng Miao

Tina Tan

Andrew Ng

Brad Hammerson

Howell Moffett

Laura Baker

Paul Sample

Scott Boyken

Ty Crowl

Andrew Ramsey

Brian Weitzner

Jared Hammer

Joshua Scheck

Leah Tait

Robert Bader

Sean Merillat

Willimark Obenza
Board of Directors

Vasudev Bailey, PhD
Partner, Artis Ventures

Scott Boyken, PhD
CSO, Outpace Bio

Marc Lajoie, PhD
CEO, Outpace Bio
Investors







